Not surprisingly, Parkin overexpression in an AD mouse model (that is based on altered amyloid precursor protein processing, i.e., APPswe/PSEN1ΔE9 mutant) was found to reduce β-amyloid load and improve hippocampal long term potentiation (Hong et al., 2014). This evidence concerns the gene PRKN and Alzheimer disease.